Former J&K Governor Satya Pal Malik hospitalised in Delhi, condition critical
Earlier on Thursday, the CBI chargesheeted the former Rajya Sabha MP in connection with an alleged corruption case in which civil works contracts for the Kiru Hydroelectric Power Project, valued at approximately Rs 2,200 crore, were awarded.However, sources close to him have strongly denied his involvement in the case, calling the move politically motivated."We were the complainants in this case. Satyapal Malik has no involvement whatsoever," his close aide said. "This chargesheet appears to be an act of vendetta politics".Malik, who has previously served as the Governor of multiple states, including Jammu and Kashmir and Goa, has often been vocal on matters of public integrity and national interest.His deteriorating health has prompted reactions from several political and civil society leaders, who are keeping a close watch on both his medical and legal situations.Must Watch
IN THIS STORY#Jammu and Kashmir
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
32 minutes ago
- Business Standard
Sagility India gains after Q1 PAT soars 566% YoY to Rs 149 cr
Sagility India advanced 6.91% to Rs 45.34 after the company's consolidated net profit surged 566.49% to Rs 148.56 crore on a 25.8% jump in revenue from operations to Rs 1,538.94 crore in Q1 FY26 over Q1 FY25. Profit before tax (PBT) stood at Rs 210.39 crore in Q1 FY26, registering a surge of 196.3% compared to Rs 71.01 crore in Q1 FY25. In Q1 FY26, adjusted EBITDA stood at Rs 368.7 crore, up 26.44%, compared with Rs 291.6 crore posted in the same quarter last year. Adjusted EBITDA margin stood at 24% in Q1 FY26 as against 23.8% in Q1 FY25. In dollar terms, the company reported revenue of $180.4 million, while adjusted PAT stood at $23.4 million in Q1 FY26. As of 31st March 2025, the company had 39,917 employees. Attrition improved to 27.6% in Q1 FY26 as against 27.3% in Q1 FY25. Ramesh Gopalan, managing director and group CEO, said, Weve entered FY26 with strong momentum and confidence in our position as a leading provider of solutions and services for U.S. healthcare payers and providers. Despite ongoing regulatory and policy shifts, our business continues to demonstrate resilience and sustained growth. We are deepening engagement with both long-standing and newer clients while maintaining robust profitability. The integration of BroadPath is progressing smoothly. As our clients contend with increasing cost pressures, we are partnering with them to bring our domain and solution capabilities, along with automation and AI, to improve efficiencies and deliver better business outcomes. Sarvabhouman Srinivasan, Group Chief Financial Officer, added, We have started FY26 with a healthy revenue momentum and disciplined execution driving balanced financial performance. Margins remain stable, supported by improved delivery efficiency, cost optimization, and early gains from BroadPath integration. Cash generation continues to be robust, enabling us to fund strategic priorities and maintain financial flexibility. Our financial strategy remains focused: investing where it matters, operating efficiently, and ensuring that every growth initiative contributes to long-term value. Sagility India provides healthcare-focused, technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.
Time of India
35 minutes ago
- Time of India
Blinkit pilots 10-minute delivery for prescription medicines in Bengaluru
Academy Empower your mind, elevate your skills Eternal-owned quick commerce platform Blinkit has started delivery of prescription medicines in select localities in Bengaluru . This will be in addition to the over-the-counter (OTC) medicine already available on the is delivering antibiotics, eye and ear drops, antihistamines and diabetes monitoring devices and drugs under its newly launched drug delivery service. It is also offering dermatological, oral care and neuro care delivery times vary between 10–30 minutes depending on the pincodes. There is no clarity on where Blinkit will source the medicines from or the underlying supply chain for the has emailed queries on the development to Blinkit, but is yet to get a was the first to report the development.A Crisil report on the online pharmacy market estimated that epharmacies currently make up 3–5% of India's pharmaceutical retail market, compared to 22–25% in some developed countries. The analytics firm valued the overall retail pharmacy market in the neighbourhood of Rs 2.4 lakh crore, with the unorganised sector representing an 85% drug delivery apps have grown in recent months. PhonePe's Pincode introduced 10-minute medicine deliveries in Bengaluru, Pune, and Mumbai in April. Eternal 's rival, Swiggy , reportedly partnered with Pharmeasy last year for quick delivery of medicines. Larger epharmacy platforms, including Tata 1mg and Netmeds, are also vying for rapid private pharmacy chain Davaindia has started 60-minute deliveries in Pune. Zeelab Pharmacy, which raised $2.4 million from OTP Ventures earlier this year, has started 60-minute deliveries in this enthusiasm is beset by the prospect of tighter regulations. Currently, there are no specific rules that exclusively govern online pharmacies. To remedy this, the government is preparing a new law to replace the existing drug regulations, which are not clearly defined, ET reported on June is already running a 10-minute ambulance service in Gurugram, scaling the number of vehicles from 5 in January to 12. These ambulances have responded to 594 calls so far, half of which were critical emergencies, Eternal 's chief executive Deepinder Goyal said in a social media post on July 24. They were able to reach patients in 10 minutes 83% of the time, Goyal company is now building an in-house paramedic training programme to expand its emergency care online medicine pilot comes as Eternal leans more on Blinkit in the backdrop of sluggishness in the food delivery business. The quick commerce player became the leading vertical for its parent in the April-June quarter, surpassing the net order value of the more mature food delivery arm, Zomato, and driving the 70% jump in is moving to an inventory-led model from September 1, which is likely to drive margin expansion , according to analysts.
Hans India
an hour ago
- Hans India
India experienced 41 outbreaks of bird flu in 10 states in 2025: Centre
India has experienced 41 outbreaks of bird flu, mainly in 10 states in 2025, said the Union government, indicating the continued rise in avian activity in the country. In a written reply to the Rajya Sabha, Union Minister of State for Fisheries, Animal Husbandry and Dairying, Prof. S.P. Singh Baghel, confirmed infections caused by the bird flu virus in non-avian species like tiger, lion, leopard, and domestic cats. This indicates a broader host range than typically expected and increases the risk of spillover events to humans. However, compared to the last five years, 2025 has recorded fewer outbreaks from the H9N1 virus. 'Till July 24, 41 cases have been recorded this year, compared to 49 in 2024. The highest number of cases in the last five years was in 2021, with 118 reported incidents,' Baghel said. 'The lowest was in 2023, with 15 reported incidents,' he added. The Minister revealed that bird flu outbreaks in domestic poultry have been reported from Maharashtra, Chhattisgarh, Jharkhand, Andhra Pradesh, Madhya Pradesh, Telangana, Karnataka, Bihar, Uttar Pradesh, and Odisha. To address the growing threat, Baghel noted that the government has undertaken multiple initiatives aimed at prevention, surveillance, and rapid response. The government formulated the National Action Plan for Prevention, Control, and Containment of Avian Influenza (Revised 2021) to provide comprehensive guidelines for preparedness, identification, and notification of affected areas, culling operations, and implementation of biosecurity measures, among others. Advisories have been issued to all States/UTs to enhance preparedness ahead of the winter migratory bird season, including strengthening surveillance in high-risk areas in coordination with wildlife and health authorities. A Poultry Disease Action Plan, 2024, has also been developed to build a resilient and disease-free poultry sector. Further, the States/UTs are financially supported on a sharing basis for compensating affected poultry owners for the culling of birds. Financial support is also provided for the establishment and strengthening of laboratories, research and innovation, capacity building, and training/awareness on topics like good animal husbandry practices, biosecurity/sanitary measures, timely reporting of unusual mortality events, etc. A National Joint Outbreak Response Team (NJORT) comprising representatives from the Department of Animal Husbandry & Dairying, National Centre for Disease Control, Indian Council of Medical Research, and Indian Council of Agriculture Research has been constituted to investigate outbreaks and coordinate field investigations and support for control and containment operations. The use of Low Pathogenic Avian Influenza (H9N2) vaccine has also been permitted using an indigenous seed strain, adding a tool to support disease prevention in the country, the Minister said.
